drug · small molecule
dordaviprone hydrochloride
Marketedupdated 3mo agoby $JAZZ Jazz Pharmaceuticals plc🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Unknown, with 1 investigational indication.
indications
investigational
Glioblastoma
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Aug 6, 2030
~4.0 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (7)
- Jan 30, 2037method-of-use (U-4254)US 10172862
- Jan 30, 2037method-of-use (U-4254)US 10369154
- Jan 30, 2037method-of-use (U-4254)US 12102639
- Mar 1, 2036formulationUS 11976068
- Jul 26, 2034formulationUS 9265765
- Apr 30, 2032method-of-use (U-4254)US 9629842
- Apr 30, 2032method-of-use (U-4254)US RE46290
FDA exclusivities (1)
- Aug 6, 2030NCENew Chemical Entity (5y)4.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 43m ago
Found something off?
comments(0)
5-min edit window · permanent after that